Tirzepatide, sold under the brand name Mounjaro by US pharmaceutical giant Eli Lilly, is currently approved to treat type 2 diabetes in the United States, Europe and most recently the UK
Increasing bioavailability of (R)-alpha-lipoic acid to boost antioxidant activity in the treatment of neuropathic pain
References Bruno BJ, Miller GD, Lim CS
Here are some of the most common contraindications for semaglutide for weight loss: History of thyroid cancer: Semaglutide has been shown to cause thyroid tumors in animals, and therefore, it is not recommended for individuals with a history of thyroid cancer or those with a family history of medullary thyroid carcinoma (MTC)
Bays HE, Chapman RH, Grandy S, SHIELD Investigators Group
Compounded semaglutide in injection, tablet, drop, and microdose formats